Donor type, in addition to transplantation in chronic phase and myeloablative conditioning, influence transplant survival for patients with advanced chronic myeloid leukemia in the era of tyrosine kinase inhibitors.

Leukemia

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.

Published: July 2017

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192023	PMC
http://dx.doi.org/10.1038/leu.2017.118	DOI Listing

Publication Analysis

donor type

type addition

addition transplantation

transplantation chronic

chronic phase

phase myeloablative

myeloablative conditioning

conditioning influence

influence transplant

transplant survival

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!